Amarin (AMRN) Reports Q1 2026 Earnings with Revenue Growth and Reduced Operating Loss
Amarin (AMRN) reported Q1 2026 earnings with total net revenue of $45.1 million, up from $42 million, driven by growth in European and Rest of World segments. The company also saw a reduction in operating loss to $11.3 million, down from $16.8 million year over year, despite ongoing generic competition for its product VASCEPA.
Tickers: $AMRN
Topics: debt earnings financial performance market share operating expenses revenue